Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Ítems similars

• Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
  per: Ben-Shlomo, Anat, et al.
  Publicat: (2009)
• Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
  per: Ben-Shlomo, Anat, et al.
  Publicat: (2009)
• Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis
  per: Ben-Shlomo, Anat, et al.
  Publicat: (2013)
• Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
  per: Liu, Ning-Ai, et al.
  Publicat: (2011)
• Pituitary Somatostatin Receptor Signaling
  per: Ben-Shlomo, Anat, et al.
  Publicat: (2010)